GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Taiwan Biomateiral Co Ltd (ROCO:6649) » Definitions » EV-to-Revenue

Taiwan Biomateiral Co (ROCO:6649) EV-to-Revenue : 14.65 (As of May. 21, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Taiwan Biomateiral Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Taiwan Biomateiral Co's enterprise value is NT$1,004.29 Mil. Taiwan Biomateiral Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was NT$68.57 Mil. Therefore, Taiwan Biomateiral Co's EV-to-Revenue for today is 14.65.

The historical rank and industry rank for Taiwan Biomateiral Co's EV-to-Revenue or its related term are showing as below:

ROCO:6649' s EV-to-Revenue Range Over the Past 10 Years
Min: 8.82   Med: 40   Max: 5488.4
Current: 14.64

During the past 11 years, the highest EV-to-Revenue of Taiwan Biomateiral Co was 5488.40. The lowest was 8.82. And the median was 40.00.

ROCO:6649's EV-to-Revenue is ranked worse than
86.27% of 830 companies
in the Medical Devices & Instruments industry
Industry Median: 3.265 vs ROCO:6649: 14.64

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-21), Taiwan Biomateiral Co's stock price is NT$29.40. Taiwan Biomateiral Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was NT$1.62. Therefore, Taiwan Biomateiral Co's PS Ratio for today is 18.13.


Taiwan Biomateiral Co EV-to-Revenue Historical Data

The historical data trend for Taiwan Biomateiral Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiwan Biomateiral Co EV-to-Revenue Chart

Taiwan Biomateiral Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 57.00 46.89 17.89 9.37 14.71

Taiwan Biomateiral Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.39 10.63 11.79 14.71 15.69

Competitive Comparison of Taiwan Biomateiral Co's EV-to-Revenue

For the Medical Devices subindustry, Taiwan Biomateiral Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taiwan Biomateiral Co's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Taiwan Biomateiral Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Taiwan Biomateiral Co's EV-to-Revenue falls into.



Taiwan Biomateiral Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Taiwan Biomateiral Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1004.286/68.574
=14.65

Taiwan Biomateiral Co's current Enterprise Value is NT$1,004.29 Mil.
Taiwan Biomateiral Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$68.57 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Taiwan Biomateiral Co  (ROCO:6649) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Taiwan Biomateiral Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=29.40/1.622
=18.13

Taiwan Biomateiral Co's share price for today is NT$29.40.
Taiwan Biomateiral Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1.62.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Taiwan Biomateiral Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Taiwan Biomateiral Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Taiwan Biomateiral Co (ROCO:6649) Business Description

Traded in Other Exchanges
N/A
Address
Section 1, Shengyi Road, 1st Floor, No. 188, Hsinchu County, Zhubei, TWN, 302
Taiwan Biomateiral Co Ltd is an applied technology Research and Development Institute in Taiwan. It is engaged in the research and development and sales of implantable medical devices. The company's products include Foamagen, stroke interventional treatment devices.

Taiwan Biomateiral Co (ROCO:6649) Headlines

No Headlines